Atara Biotherapeutics ATRA
NASDAQ ATRA
$8.46 -0.04 (-0.47%)
At close: Oct 1, 2026 · 4:00 PM EDT

Atara Biotherapeutics (ATRA) Cash from Financing Activities (2013 - 2026)

Updated

Atara Biotherapeutics (ATRA) recorded Cash from Financing Activities of $4.83 million in Q2 2026, down 68.5% from $15.3 million a year earlier but up 63.5% from the prior quarter.

Analysis

Atara Biotherapeutics (ATRA) Cash from Financing Activities (2013 - 2026) Analysis & Trends

On a TTM basis, Atara Biotherapeutics' Cash from Financing Activities came in at $8.82 million as of Jun 30, 2026, down 82.5% year-over-year; for FY2025, it was $16.1 million, down 72.8% from FY2024.

  • Annual Cash from Financing Activities has a five-year compound annual growth rate of -48.1% (FY2020 to FY2025).
  • Across earlier years, Cash from Financing Activities came in at $59.28 million in FY2024, $2.01 million in FY2023 (-96.2%), $53.08 million in FY2022 (-48.9%) and $103.94 million in FY2021 (-75.7%).
  • Quarterly Cash from Financing Activities has ranged from -$328,000 in Q4 2024 to $51.47 million in Q4 2021 over the past five years.
  • Peak year-over-year performance for Cash from Financing Activities in the last five years was growth of 586.4% in Q1 2022, against a decline of 98.8% in Q1 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at $2.95 million (Q1 2026), -$3,000 (Q4 2025) and $1.05 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -8.78 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -5.05 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.02 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -47.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -1.48 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 2.34 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -3.66 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -426.70 Mn
10 Atara Biotherapeutics 127.78 Mn 117.88 Mn 439,000.00 4.83 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.83 Mn
Mar 31, 2026 2.95 Mn
Dec 31, 2025 -3,000.00
Sep 30, 2025 1.05 Mn
Jun 30, 2025 15.30 Mn
Mar 31, 2025 -250,000.00
Dec 31, 2024 -328,000.00
Sep 30, 2024 35.79 Mn
Jun 30, 2024 -324,000.00
Mar 31, 2024 24.14 Mn
Dec 31, 2023 1.51 Mn
Sep 30, 2023 -208,000.00
Jun 30, 2023 471,000.00
Mar 31, 2023 235,000.00
Dec 31, 2022 32.29 Mn
Sep 30, 2022 -214,000.00
Jun 30, 2022 1.16 Mn
Mar 31, 2022 19.85 Mn
Dec 31, 2021 51.47 Mn
Sep 30, 2021 47.14 Mn
API Access

Atara Biotherapeutics Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=ATRA&period=max&api_key=YOUR_API_KEY